Vestor Capital LLC Sells 45,713 Shares of McKesson Co. (NYSE:MCK)

Vestor Capital LLC trimmed its holdings in McKesson Co. (NYSE:MCK) by 98.3% in the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 773 shares of the company’s stock after selling 45,713 shares during the quarter. Vestor Capital LLC’s holdings in McKesson were worth $382,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Swedbank AB purchased a new stake in shares of McKesson during the 1st quarter valued at about $669,326,000. International Assets Investment Management LLC raised its holdings in shares of McKesson by 1,020.2% during the third quarter. International Assets Investment Management LLC now owns 806,878 shares of the company’s stock valued at $398,937,000 after purchasing an additional 734,849 shares during the last quarter. Bessemer Group Inc. lifted its position in McKesson by 3,621.7% during the first quarter. Bessemer Group Inc. now owns 349,395 shares of the company’s stock valued at $187,572,000 after purchasing an additional 340,007 shares during the period. Bristol Gate Capital Partners Inc. purchased a new stake in McKesson in the first quarter worth approximately $97,510,000. Finally, Assenagon Asset Management S.A. grew its position in McKesson by 581.0% in the 3rd quarter. Assenagon Asset Management S.A. now owns 151,240 shares of the company’s stock worth $74,776,000 after purchasing an additional 129,031 shares during the period. 85.07% of the stock is currently owned by institutional investors.

McKesson Stock Up 5.1 %

NYSE:MCK opened at $526.34 on Monday. The business’s 50-day simple moving average is $512.00 and its two-hundred day simple moving average is $550.57. McKesson Co. has a 52 week low of $431.35 and a 52 week high of $637.51. The stock has a market cap of $68.26 billion, a PE ratio of 23.54, a P/E/G ratio of 1.17 and a beta of 0.44.

McKesson (NYSE:MCK) last posted its quarterly earnings results on Wednesday, August 7th. The company reported $7.88 EPS for the quarter, topping analysts’ consensus estimates of $7.21 by $0.67. McKesson had a negative return on equity of 242.57% and a net margin of 0.94%. The company had revenue of $79.28 billion for the quarter, compared to analysts’ expectations of $82.53 billion. During the same period in the previous year, the firm earned $7.27 EPS. The firm’s revenue was up 6.4% compared to the same quarter last year. Sell-side analysts anticipate that McKesson Co. will post 31.92 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, January 2nd. Investors of record on Monday, December 2nd will be paid a dividend of $0.71 per share. The ex-dividend date of this dividend is Monday, December 2nd. This represents a $2.84 annualized dividend and a yield of 0.54%. McKesson’s payout ratio is 12.70%.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on MCK. JPMorgan Chase & Co. increased their price target on McKesson from $656.00 to $661.00 and gave the company an “overweight” rating in a report on Wednesday, August 21st. StockNews.com cut McKesson from a “buy” rating to a “hold” rating in a research report on Friday, September 27th. Robert W. Baird reaffirmed a “neutral” rating and set a $531.00 price target (down previously from $603.00) on shares of McKesson in a research report on Tuesday, September 24th. Baird R W downgraded shares of McKesson from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 24th. Finally, Deutsche Bank Aktiengesellschaft cut their target price on shares of McKesson from $623.00 to $579.00 and set a “buy” rating for the company in a research report on Wednesday, September 25th. Five equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat.com, McKesson has a consensus rating of “Moderate Buy” and a consensus price target of $610.86.

Insider Buying and Selling at McKesson

In other news, CEO Brian S. Tyler sold 3,753 shares of the firm’s stock in a transaction dated Thursday, September 5th. The stock was sold at an average price of $561.10, for a total transaction of $2,105,808.30. Following the completion of the transaction, the chief executive officer now owns 78,586 shares in the company, valued at $44,094,604.60. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 0.11% of the stock is currently owned by insiders.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.